Sandbox : anmol: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 52: Line 52:
|
|
* Decreased serum [[sodium]]
* Decreased serum [[sodium]]
|*N/A
|
*N/A
|
|
* Decreased [[bicarbonate]]
* Decreased [[bicarbonate]]
Line 60: Line 61:
* Elevated hepatic [[transaminases]]
* Elevated hepatic [[transaminases]]
* Toxicology screen for [[acetaminophen]] and [[salicylates]]
* Toxicology screen for [[acetaminophen]] and [[salicylates]]
|*N/A
|
|*N/A
*N/A
|A*N/AN/
|
|*N/A
*N/A
|*N/A
|
*N/A
|
*N/A
|
*N/A
|
|
* Serum [[osmolality]] should be calculated
* Serum [[osmolality]] should be calculated
Line 80: Line 86:
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|*N/A
|
|*N/A
*N/A
|*N/A
|
|*N/A
*N/A
|*N/A
|
*N/A
|
*N/A
|
*N/A
|
|
* [[Aspergillus]] precipitins [[allergy test]] is positive
* [[Aspergillus]] precipitins [[allergy test]] is positive
Line 94: Line 105:
*** Hyphae are demonstrated
*** Hyphae are demonstrated
*** Elevated galactomannan level in bronchoalveolar fluid   
*** Elevated galactomannan level in bronchoalveolar fluid   
|*N/A
|
*N/A
|
|
* Pulmonary infiltrates
* Pulmonary infiltrates
Line 106: Line 118:
* May show evidence of wedge-shaped pulmonary [[infarction]]
* May show evidence of wedge-shaped pulmonary [[infarction]]
* Granulomata, tissue [[necrosis]], and blood vessel invasion may be noted
* Granulomata, tissue [[necrosis]], and blood vessel invasion may be noted
|*N/A
|
|*N/A
*N/A
|
*N/A
|
|
* [[Polymerase chain reaction]] (PCR) assays could be useful in diagnosis of invasive [[aspergillosis]]  
* [[Polymerase chain reaction]] (PCR) assays could be useful in diagnosis of invasive [[aspergillosis]]  
Line 132: Line 146:
* Elevated [[calcium]]
* Elevated [[calcium]]
* Elevated [[magnesium]]
* Elevated [[magnesium]]
|*N/A
|
*N/A
|
|
* Elevated [[lactate]]
* Elevated [[lactate]]
Line 143: Line 158:
* Elevated serum-specific gravity is noted
* Elevated serum-specific gravity is noted
* Elevated blood [[glucose]] may be detected
* Elevated blood [[glucose]] may be detected
|*N/A
|
|*N/A
*N/A
|*N/A
|
|*N/A
*N/A
|*N/A
|
|*N/A
*N/A
|
*N/A
|
*N/A
|
*N/A
|-
|-
|'''[[Congestive heart failure]] (CHF)'''<ref name="pmid17724259">{{cite journal |vauthors=Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA |title=Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure |journal=Circulation |volume=116 |issue=13 |pages=1482–7 |date=September 2007 |pmid=17724259 |doi=10.1161/CIRCULATIONAHA.107.696906 |url=}}</ref><ref name="pmid15687312">{{cite journal |vauthors=Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ |title=Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis |journal=JAMA |volume=293 |issue=5 |pages=572–80 |date=February 2005 |pmid=15687312 |doi=10.1001/jama.293.5.572 |url=}}</ref><ref name="pmid12798577">{{cite journal |vauthors=Kittleson M, Hurwitz S, Shah MR, Nohria A, Lewis E, Givertz M, Fang J, Jarcho J, Mudge G, Stevenson LW |title=Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality |journal=J. Am. Coll. Cardiol. |volume=41 |issue=11 |pages=2029–35 |date=June 2003 |pmid=12798577 |doi= |url=}}</ref><ref name="pmid17602982">{{cite journal |vauthors=Filippatos G, Rossi J, Lloyd-Jones DM, Stough WG, Ouyang J, Shin DD, O'connor C, Adams KF, Orlandi C, Gheorghiade M |title=Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study |journal=J. Card. Fail. |volume=13 |issue=5 |pages=360–4 |date=June 2007 |pmid=17602982 |doi=10.1016/j.cardfail.2007.02.005 |url=}}</ref><ref name="pmid22554602">{{cite journal |vauthors=Zamora E, Lupón J, Vila J, Urrutia A, de Antonio M, Sanz H, Grau M, Ara J, Bayés-Genís A |title=Estimated glomerular filtration rate and prognosis in heart failure: value of the Modification of Diet in Renal Disease Study-4, chronic kidney disease epidemiology collaboration, and cockroft-gault formulas |journal=J. Am. Coll. Cardiol. |volume=59 |issue=19 |pages=1709–15 |date=May 2012 |pmid=22554602 |doi=10.1016/j.jacc.2011.11.066 |url=}}</ref><ref name="pmid22441773">{{cite journal |vauthors=McAlister FA, Ezekowitz J, Tarantini L, Squire I, Komajda M, Bayes-Genis A, Gotsman I, Whalley G, Earle N, Poppe KK, Doughty RN |title=Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula |journal=Circ Heart Fail |volume=5 |issue=3 |pages=309–14 |date=May 2012 |pmid=22441773 |doi=10.1161/CIRCHEARTFAILURE.111.966242 |url=}}</ref>
|'''[[Congestive heart failure]] (CHF)'''<ref name="pmid17724259">{{cite journal |vauthors=Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA |title=Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure |journal=Circulation |volume=116 |issue=13 |pages=1482–7 |date=September 2007 |pmid=17724259 |doi=10.1161/CIRCULATIONAHA.107.696906 |url=}}</ref><ref name="pmid15687312">{{cite journal |vauthors=Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ |title=Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis |journal=JAMA |volume=293 |issue=5 |pages=572–80 |date=February 2005 |pmid=15687312 |doi=10.1001/jama.293.5.572 |url=}}</ref><ref name="pmid12798577">{{cite journal |vauthors=Kittleson M, Hurwitz S, Shah MR, Nohria A, Lewis E, Givertz M, Fang J, Jarcho J, Mudge G, Stevenson LW |title=Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality |journal=J. Am. Coll. Cardiol. |volume=41 |issue=11 |pages=2029–35 |date=June 2003 |pmid=12798577 |doi= |url=}}</ref><ref name="pmid17602982">{{cite journal |vauthors=Filippatos G, Rossi J, Lloyd-Jones DM, Stough WG, Ouyang J, Shin DD, O'connor C, Adams KF, Orlandi C, Gheorghiade M |title=Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study |journal=J. Card. Fail. |volume=13 |issue=5 |pages=360–4 |date=June 2007 |pmid=17602982 |doi=10.1016/j.cardfail.2007.02.005 |url=}}</ref><ref name="pmid22554602">{{cite journal |vauthors=Zamora E, Lupón J, Vila J, Urrutia A, de Antonio M, Sanz H, Grau M, Ara J, Bayés-Genís A |title=Estimated glomerular filtration rate and prognosis in heart failure: value of the Modification of Diet in Renal Disease Study-4, chronic kidney disease epidemiology collaboration, and cockroft-gault formulas |journal=J. Am. Coll. Cardiol. |volume=59 |issue=19 |pages=1709–15 |date=May 2012 |pmid=22554602 |doi=10.1016/j.jacc.2011.11.066 |url=}}</ref><ref name="pmid22441773">{{cite journal |vauthors=McAlister FA, Ezekowitz J, Tarantini L, Squire I, Komajda M, Bayes-Genis A, Gotsman I, Whalley G, Earle N, Poppe KK, Doughty RN |title=Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula |journal=Circ Heart Fail |volume=5 |issue=3 |pages=309–14 |date=May 2012 |pmid=22441773 |doi=10.1161/CIRCHEARTFAILURE.111.966242 |url=}}</ref>
Line 170: Line 191:
* Serum [[sodium]] may be decreased
* Serum [[sodium]] may be decreased
* Serum [[potassium]] may be elevated
* Serum [[potassium]] may be elevated
|*N/A
|
*N/A
|
|
* Serum [[bicarbonate]] may be decreased  
* Serum [[bicarbonate]] may be decreased  
Line 179: Line 201:
* Cardiac [[troponin]]s may be elevated  
* Cardiac [[troponin]]s may be elevated  
* [[Pulse oximetry]] may indicate [[hypoxemia]]
* [[Pulse oximetry]] may indicate [[hypoxemia]]
|*N/A
|
*N/A
|
|
* May demonstrate:
* May demonstrate:
Line 187: Line 210:
|
|
* More accurate visualization of [[pulmonary edema]]
* More accurate visualization of [[pulmonary edema]]
|*N/A
|
*N/A
|
|
* Useful in detecting congenital cardiac anomalies and assessment [[valvular heart disease]]
* Useful in detecting congenital cardiac anomalies and assessment [[valvular heart disease]]
Line 198: Line 222:
** ECG-gated myocardial perfusion imaging
** ECG-gated myocardial perfusion imaging
** ECG-gated single-photon emission CT
** ECG-gated single-photon emission CT
|*N/A
|
*N/A
|-
|-
|[[Dehydration|'''Dehydration''']]<ref name="pmid15187057">{{cite journal |vauthors=Steiner MJ, DeWalt DA, Byerley JS |title=Is this child dehydrated? |journal=JAMA |volume=291 |issue=22 |pages=2746–54 |date=June 2004 |pmid=15187057 |doi=10.1001/jama.291.22.2746 |url=}}</ref><ref name="pmid9220501">{{cite journal |vauthors=Vega RM, Avner JR |title=A prospective study of the usefulness of clinical and laboratory parameters for predicting percentage of dehydration in children |journal=Pediatr Emerg Care |volume=13 |issue=3 |pages=179–82 |date=June 1997 |pmid=9220501 |doi= |url=}}</ref><ref name="pmid5928490">{{cite journal |vauthors=Dossetor JB |title=Creatininemia versus uremia. The relative significance of blood urea nitrogen and serum creatinine concentrations in azotemia |journal=Ann. Intern. Med. |volume=65 |issue=6 |pages=1287–99 |date=December 1966 |pmid=5928490 |doi= |url=}}</ref><ref name="pmid2198971">{{cite journal |vauthors=Baskett PJ |title=ABC of major trauma. Management of hypovolaemic shock |journal=BMJ |volume=300 |issue=6737 |pages=1453–7 |date=June 1990 |pmid=2198971 |pmc=1663124 |doi= |url=}}</ref>
|[[Dehydration|'''Dehydration''']]<ref name="pmid15187057">{{cite journal |vauthors=Steiner MJ, DeWalt DA, Byerley JS |title=Is this child dehydrated? |journal=JAMA |volume=291 |issue=22 |pages=2746–54 |date=June 2004 |pmid=15187057 |doi=10.1001/jama.291.22.2746 |url=}}</ref><ref name="pmid9220501">{{cite journal |vauthors=Vega RM, Avner JR |title=A prospective study of the usefulness of clinical and laboratory parameters for predicting percentage of dehydration in children |journal=Pediatr Emerg Care |volume=13 |issue=3 |pages=179–82 |date=June 1997 |pmid=9220501 |doi= |url=}}</ref><ref name="pmid5928490">{{cite journal |vauthors=Dossetor JB |title=Creatininemia versus uremia. The relative significance of blood urea nitrogen and serum creatinine concentrations in azotemia |journal=Ann. Intern. Med. |volume=65 |issue=6 |pages=1287–99 |date=December 1966 |pmid=5928490 |doi= |url=}}</ref><ref name="pmid2198971">{{cite journal |vauthors=Baskett PJ |title=ABC of major trauma. Management of hypovolaemic shock |journal=BMJ |volume=300 |issue=6737 |pages=1453–7 |date=June 1990 |pmid=2198971 |pmc=1663124 |doi= |url=}}</ref>
Line 218: Line 243:
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|*N/A
|
*N/A
|
|
* Elevated [[BUN]]
* Elevated [[BUN]]
Line 234: Line 260:
|
|
* [[Hypoglycemia]] may be detected
* [[Hypoglycemia]] may be detected
|*N/A
|
|*N/A
*N/A
|*N/A
|
|*N/A
*N/A
|*N/A
|
*N/A
|
*N/A
|
*N/A
|
|
* [[Oral rehydration therapy]] is the usual line of treatment  
* [[Oral rehydration therapy]] is the usual line of treatment  
Line 256: Line 287:
* [[Leukocytosis]] with predominant [[neutrophilia]] may be detected  
* [[Leukocytosis]] with predominant [[neutrophilia]] may be detected  
* Elevated [[ESR]] may be detected
* Elevated [[ESR]] may be detected
|*N/A
|
*N/A
|
|
* Stool anion gap should be calculated
* Stool anion gap should be calculated
Line 266: Line 298:
** [[Porphobilinogen]]
** [[Porphobilinogen]]
** [[Aminolevulinic acid]]  
** [[Aminolevulinic acid]]  
|*N/A
|
*N/A
|
|
* Stool pH < 5.5
* Stool pH < 5.5
Line 278: Line 311:
|
|
* Upper gastrointestinal radiography with follow-through may be useful to detect cause
* Upper gastrointestinal radiography with follow-through may be useful to detect cause
|*N/A
|
*N/A
|
|
* Brain MRI may be useful to detect cause
* Brain MRI may be useful to detect cause
Line 319: Line 353:
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|*N/A
|
*N/A
|
|
* Elevated [[BUN]]
* Elevated [[BUN]]
Line 352: Line 387:
* Some radio-opaque substances may be visualized
* Some radio-opaque substances may be visualized
* Ingested drug packets may also be visualized
* Ingested drug packets may also be visualized
|*N/A
|
|*N/A
*N/A
|
*N/A
|
|
* [[ECG]] may be helpful in diagnosing [[arrhythmia]]s
* [[ECG]] may be helpful in diagnosing [[arrhythmia]]s
|*N/A
|
*N/A
|-
|-
|[[Esophageal varices|'''Esophageal varices bleeding''']]<ref name="pmid6970703">{{cite journal |vauthors=Graham DY, Smith JL |title=The course of patients after variceal hemorrhage |journal=Gastroenterology |volume=80 |issue=4 |pages=800–9 |date=April 1981 |pmid=6970703 |doi= |url=}}</ref><ref name="pmid20638742">{{cite journal |vauthors=de Franchis R |title=Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension |journal=J. Hepatol. |volume=53 |issue=4 |pages=762–8 |date=October 2010 |pmid=20638742 |doi=10.1016/j.jhep.2010.06.004 |url=}}</ref>
|[[Esophageal varices|'''Esophageal varices bleeding''']]<ref name="pmid6970703">{{cite journal |vauthors=Graham DY, Smith JL |title=The course of patients after variceal hemorrhage |journal=Gastroenterology |volume=80 |issue=4 |pages=800–9 |date=April 1981 |pmid=6970703 |doi= |url=}}</ref><ref name="pmid20638742">{{cite journal |vauthors=de Franchis R |title=Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension |journal=J. Hepatol. |volume=53 |issue=4 |pages=762–8 |date=October 2010 |pmid=20638742 |doi=10.1016/j.jhep.2010.06.004 |url=}}</ref>
Line 376: Line 414:
** Elevated [[BUN]]
** Elevated [[BUN]]
** Elevated [[creatinine]]
** Elevated [[creatinine]]
|*N/A
|
|*N/A
*N/A
|*N/A
|
|*N/A
*N/A
|
*N/A
|
*N/A
|
|
* Duplex doppler [[ultrasonography]] can determine:
* Duplex doppler [[ultrasonography]] can determine:
Line 401: Line 443:
* A flexible [[endoscope]] may also aid diagnosis
* A flexible [[endoscope]] may also aid diagnosis
* Bleeding is stopped by [[vasopressin]], balloon tamponade, or [[transjugular intrahepatic portosystemic shunt]] to name a few.
* Bleeding is stopped by [[vasopressin]], balloon tamponade, or [[transjugular intrahepatic portosystemic shunt]] to name a few.
|*N/A
|
*N/A
|-
|-
|'''[[Heart disease]]'''<ref name="pmid2030718">{{cite journal |vauthors=LaCroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, Curb JD, Evans D, Hennekens CH |title=Smoking and mortality among older men and women in three communities |journal=N. Engl. J. Med. |volume=324 |issue=23 |pages=1619–25 |date=June 1991 |pmid=2030718 |doi=10.1056/NEJM199106063242303 |url=}}</ref><ref name="pmid19581259">{{cite journal |vauthors=Mahle WT, Newburger JW, Matherne GP, Smith FC, Hoke TR, Koppel R, Gidding SS, Beekman RH, Grosse SD |title=Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP |journal=Pediatrics |volume=124 |issue=2 |pages=823–36 |date=August 2009 |pmid=19581259 |doi=10.1542/peds.2009-1397 |url=}}</ref>
|'''[[Heart disease]]'''<ref name="pmid2030718">{{cite journal |vauthors=LaCroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, Curb JD, Evans D, Hennekens CH |title=Smoking and mortality among older men and women in three communities |journal=N. Engl. J. Med. |volume=324 |issue=23 |pages=1619–25 |date=June 1991 |pmid=2030718 |doi=10.1056/NEJM199106063242303 |url=}}</ref><ref name="pmid19581259">{{cite journal |vauthors=Mahle WT, Newburger JW, Matherne GP, Smith FC, Hoke TR, Koppel R, Gidding SS, Beekman RH, Grosse SD |title=Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP |journal=Pediatrics |volume=124 |issue=2 |pages=823–36 |date=August 2009 |pmid=19581259 |doi=10.1542/peds.2009-1397 |url=}}</ref>
Line 421: Line 464:
|
|
* [[BUN]] and [[creatinine]] may be elevated
* [[BUN]] and [[creatinine]] may be elevated
|*N/A
|
|*N/A
*N/A
|*N/A
|
*N/A
|
*N/A
|
|
* For [[coronary heart disease]], [[cardiac stress testing]] may be performed:
* For [[coronary heart disease]], [[cardiac stress testing]] may be performed:
Line 441: Line 487:
** [[Dextrocardia]]
** [[Dextrocardia]]
** Abnormal cardiac silhouette
** Abnormal cardiac silhouette
|*N/A
|
|*N/A
*N/A
|
*N/A
|
|
* [[ECG]] may demonstrate:
* [[ECG]] may demonstrate:
Line 484: Line 532:
|
|
* [[BUN]] and [[creatinine]] is elevated in severe [[hemorrhage]]
* [[BUN]] and [[creatinine]] is elevated in severe [[hemorrhage]]
|*N/A
|
|*N/A
*N/A
|
*N/A
|
|
* [[pH]] may be 7.30-7.35 with mild to severe [[metabolic acidosis]]
* [[pH]] may be 7.30-7.35 with mild to severe [[metabolic acidosis]]
Line 503: Line 553:
* May visualize intrathoracic, intra-abdominal, and retroperitoneal [[bleeding]]
* May visualize intrathoracic, intra-abdominal, and retroperitoneal [[bleeding]]
* However, [[ultrasound]] is more often used  
* However, [[ultrasound]] is more often used  
|*N/A
|
*N/A
|
|
* Esophagogastroduodenoscopy is often used to visualize the source of [[bleeding]] in the upper GI
* Esophagogastroduodenoscopy is often used to visualize the source of [[bleeding]] in the upper GI
* [[Colonoscopy]] may be used in the lower GI
* [[Colonoscopy]] may be used in the lower GI
* [[Angiography]] and nuclear medicine scanning are also useful in diagnosing the source of [[bleeding]]
* [[Angiography]] and nuclear medicine scanning are also useful in diagnosing the source of [[bleeding]]
|*N/A
|
*N/A
|-
|-
|[[Hemolysis|'''Hemolysis''']]<ref name="pmid3814817">{{cite journal |vauthors=Liesveld JL, Rowe JM, Lichtman MA |title=Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases |journal=Blood |volume=69 |issue=3 |pages=820–6 |date=March 1987 |pmid=3814817 |doi= |url=}}</ref><ref name="pmid7365971">{{cite journal |vauthors=Marchand A, Galen RS, Van Lente F |title=The predictive value of serum haptoglobin in hemolytic disease |journal=JAMA |volume=243 |issue=19 |pages=1909–11 |date=May 1980 |pmid=7365971 |doi= |url=}}</ref><ref name="pmid2436855">{{cite journal |vauthors=Stahl WM |title=Acute phase protein response to tissue injury |journal=Crit. Care Med. |volume=15 |issue=6 |pages=545–50 |date=June 1987 |pmid=2436855 |doi= |url=}}</ref><ref name="pmid7411826">{{cite journal |vauthors=Conley CL, Lippman SM, Ness P |title=Autoimmune hemolytic anemia with reticulocytopenia. A medical emergency |journal=JAMA |volume=244 |issue=15 |pages=1688–90 |date=October 1980 |pmid=7411826 |doi= |url=}}</ref>
|[[Hemolysis|'''Hemolysis''']]<ref name="pmid3814817">{{cite journal |vauthors=Liesveld JL, Rowe JM, Lichtman MA |title=Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases |journal=Blood |volume=69 |issue=3 |pages=820–6 |date=March 1987 |pmid=3814817 |doi= |url=}}</ref><ref name="pmid7365971">{{cite journal |vauthors=Marchand A, Galen RS, Van Lente F |title=The predictive value of serum haptoglobin in hemolytic disease |journal=JAMA |volume=243 |issue=19 |pages=1909–11 |date=May 1980 |pmid=7365971 |doi= |url=}}</ref><ref name="pmid2436855">{{cite journal |vauthors=Stahl WM |title=Acute phase protein response to tissue injury |journal=Crit. Care Med. |volume=15 |issue=6 |pages=545–50 |date=June 1987 |pmid=2436855 |doi= |url=}}</ref><ref name="pmid7411826">{{cite journal |vauthors=Conley CL, Lippman SM, Ness P |title=Autoimmune hemolytic anemia with reticulocytopenia. A medical emergency |journal=JAMA |volume=244 |issue=15 |pages=1688–90 |date=October 1980 |pmid=7411826 |doi= |url=}}</ref>
Line 528: Line 580:
* Elevated [[red blood cell]] distribution width may indicate [[anisocytosis]]  
* Elevated [[red blood cell]] distribution width may indicate [[anisocytosis]]  
* [[Reticulocyte]] count may be increased
* [[Reticulocyte]] count may be increased
|*N/A
|
|*N/A
*N/A
|*N/A
|
|*N/A
*N/A
|
*N/A
|
*N/A
|
|
* Peripheral [[blood smear]] may demonstrate:
* Peripheral [[blood smear]] may demonstrate:
Line 552: Line 608:
|
|
** May visualize [[hepatomegaly]] or [[splenomegal]]y or [[hepatosplenomegaly]]
** May visualize [[hepatomegaly]] or [[splenomegal]]y or [[hepatosplenomegaly]]
|*N/A
|
|*N/A
*N/A
|*N/A
|
|*N/A
*N/A
|*N/A
|
*N/A
|
*N/A
|
*N/A
|-
|-
|[[Hepatorenal syndrome|'''Hepatorenal syndrome''']]<ref name="pmid19776409">{{cite journal |vauthors=Ginès P, Schrier RW |title=Renal failure in cirrhosis |journal=N. Engl. J. Med. |volume=361 |issue=13 |pages=1279–90 |date=September 2009 |pmid=19776409 |doi=10.1056/NEJMra0809139 |url=}}</ref><ref name="pmid8550036">{{cite journal |vauthors=Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Schölmerich J |title=Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club |journal=Hepatology |volume=23 |issue=1 |pages=164–76 |date=January 1996 |pmid=8550036 |doi=10.1002/hep.510230122 |url=}}</ref><ref name="pmid17389705">{{cite journal |vauthors=Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V |title=Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis |journal=Gut |volume=56 |issue=9 |pages=1310–8 |date=September 2007 |pmid=17389705 |pmc=1954971 |doi=10.1136/gut.2006.107789 |url=}}</ref><ref name="pmid25638527">{{cite journal |vauthors=Angeli P, Ginès P, Wong F, Bernardi M, Boyer TD, Gerbes A, Moreau R, Jalan R, Sarin SK, Piano S, Moore K, Lee SS, Durand F, Salerno F, Caraceni P, Kim WR, Arroyo V, Garcia-Tsao G |title=Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites |journal=J. Hepatol. |volume=62 |issue=4 |pages=968–74 |date=April 2015 |pmid=25638527 |doi=10.1016/j.jhep.2014.12.029 |url=}}</ref>
|[[Hepatorenal syndrome|'''Hepatorenal syndrome''']]<ref name="pmid19776409">{{cite journal |vauthors=Ginès P, Schrier RW |title=Renal failure in cirrhosis |journal=N. Engl. J. Med. |volume=361 |issue=13 |pages=1279–90 |date=September 2009 |pmid=19776409 |doi=10.1056/NEJMra0809139 |url=}}</ref><ref name="pmid8550036">{{cite journal |vauthors=Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Schölmerich J |title=Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club |journal=Hepatology |volume=23 |issue=1 |pages=164–76 |date=January 1996 |pmid=8550036 |doi=10.1002/hep.510230122 |url=}}</ref><ref name="pmid17389705">{{cite journal |vauthors=Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V |title=Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis |journal=Gut |volume=56 |issue=9 |pages=1310–8 |date=September 2007 |pmid=17389705 |pmc=1954971 |doi=10.1136/gut.2006.107789 |url=}}</ref><ref name="pmid25638527">{{cite journal |vauthors=Angeli P, Ginès P, Wong F, Bernardi M, Boyer TD, Gerbes A, Moreau R, Jalan R, Sarin SK, Piano S, Moore K, Lee SS, Durand F, Salerno F, Caraceni P, Kim WR, Arroyo V, Garcia-Tsao G |title=Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites |journal=J. Hepatol. |volume=62 |issue=4 |pages=968–74 |date=April 2015 |pmid=25638527 |doi=10.1016/j.jhep.2014.12.029 |url=}}</ref>
Line 582: Line 643:
* [[Urine osmolality]] > [[plasma osmolality]]
* [[Urine osmolality]] > [[plasma osmolality]]
* Urine [[red blood cell]] count < 50 per high-power field
* Urine [[red blood cell]] count < 50 per high-power field
|*N/A
|
*N/A
|
|
* Prolonged [[prothrombin time]]
* Prolonged [[prothrombin time]]
Line 589: Line 651:
|
|
* Abdominal ultrasound to exclude [[hydronephrosis]] and intrinsic renal disease
* Abdominal ultrasound to exclude [[hydronephrosis]] and intrinsic renal disease
|*N/A
|
|*N/A
*N/A
|*N/A
|
*N/A
|
*N/A
|
|
* [[Echocardiography]] is used to evaluate right ventricular preload, ventricular filling pressures, and cardiac function
* [[Echocardiography]] is used to evaluate right ventricular preload, ventricular filling pressures, and cardiac function
|*N/A
|
*N/A
|-
|-
|[[Cardiomyopathy|'''Ischemic cardiomyopathy''']]<ref name="pmid16567565">{{cite journal |vauthors=Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB |title=Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention |journal=Circulation |volume=113 |issue=14 |pages=1807–16 |date=April 2006 |pmid=16567565 |doi=10.1161/CIRCULATIONAHA.106.174287 |url=}}</ref><ref name="pmid15689345">{{cite journal |vauthors=Corrado D, Pelliccia A, Bjørnstad HH, Vanhees L, Biffi A, Borjesson M, Panhuyzen-Goedkoop N, Deligiannis A, Solberg E, Dugmore D, Mellwig KP, Assanelli D, Delise P, van-Buuren F, Anastasakis A, Heidbuchel H, Hoffmann E, Fagard R, Priori SG, Basso C, Arbustini E, Blomstrom-Lundqvist C, McKenna WJ, Thiene G |title=Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology |journal=Eur. Heart J. |volume=26 |issue=5 |pages=516–24 |date=March 2005 |pmid=15689345 |doi=10.1093/eurheartj/ehi108 |url=}}</ref><ref name="pmid17916581">{{cite journal |vauthors=Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A |title=Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases |journal=Eur. Heart J. |volume=29 |issue=2 |pages=270–6 |date=January 2008 |pmid=17916581 |doi=10.1093/eurheartj/ehm342 |url=}}</ref><ref name="pmid17468391">{{cite journal |vauthors=Thompson PD, Franklin BA, Balady GJ, Blair SN, Corrado D, Estes NA, Fulton JE, Gordon NF, Haskell WL, Link MS, Maron BJ, Mittleman MA, Pelliccia A, Wenger NK, Willich SN, Costa F |title=Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology |journal=Circulation |volume=115 |issue=17 |pages=2358–68 |date=May 2007 |pmid=17468391 |doi=10.1161/CIRCULATIONAHA.107.181485 |url=}}</ref>
|[[Cardiomyopathy|'''Ischemic cardiomyopathy''']]<ref name="pmid16567565">{{cite journal |vauthors=Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB |title=Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention |journal=Circulation |volume=113 |issue=14 |pages=1807–16 |date=April 2006 |pmid=16567565 |doi=10.1161/CIRCULATIONAHA.106.174287 |url=}}</ref><ref name="pmid15689345">{{cite journal |vauthors=Corrado D, Pelliccia A, Bjørnstad HH, Vanhees L, Biffi A, Borjesson M, Panhuyzen-Goedkoop N, Deligiannis A, Solberg E, Dugmore D, Mellwig KP, Assanelli D, Delise P, van-Buuren F, Anastasakis A, Heidbuchel H, Hoffmann E, Fagard R, Priori SG, Basso C, Arbustini E, Blomstrom-Lundqvist C, McKenna WJ, Thiene G |title=Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology |journal=Eur. Heart J. |volume=26 |issue=5 |pages=516–24 |date=March 2005 |pmid=15689345 |doi=10.1093/eurheartj/ehi108 |url=}}</ref><ref name="pmid17916581">{{cite journal |vauthors=Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A |title=Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases |journal=Eur. Heart J. |volume=29 |issue=2 |pages=270–6 |date=January 2008 |pmid=17916581 |doi=10.1093/eurheartj/ehm342 |url=}}</ref><ref name="pmid17468391">{{cite journal |vauthors=Thompson PD, Franklin BA, Balady GJ, Blair SN, Corrado D, Estes NA, Fulton JE, Gordon NF, Haskell WL, Link MS, Maron BJ, Mittleman MA, Pelliccia A, Wenger NK, Willich SN, Costa F |title=Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology |journal=Circulation |volume=115 |issue=17 |pages=2358–68 |date=May 2007 |pmid=17468391 |doi=10.1161/CIRCULATIONAHA.107.181485 |url=}}</ref>
Line 615: Line 681:
* Serum [[postassium]] may be chronically low
* Serum [[postassium]] may be chronically low
* Serum [[magnesium]] may be decreased
* Serum [[magnesium]] may be decreased
|*N/A
|
|*N/A
*N/A
|
*N/A
|
|
* [[Cardiac enzyme]]s may be elevated indicating a recent [[myocardial infarction]], and include:
* [[Cardiac enzyme]]s may be elevated indicating a recent [[myocardial infarction]], and include:
Line 623: Line 691:
** [[Creatine kinase]] - MB
** [[Creatine kinase]] - MB
* B-type natriuretic peptide level reflects volume status
* B-type natriuretic peptide level reflects volume status
|*N/A
|
*N/A
|
|
* May detect abnormal cardiac silhouette
* May detect abnormal cardiac silhouette
Line 650: Line 719:
* Right-sided heart catheterization can determine volume status
* Right-sided heart catheterization can determine volume status
* Endomyocardial biopsy may also be helpful in diagnosis
* Endomyocardial biopsy may also be helpful in diagnosis
|*N/A
|
*N/A
|-
|-
|[[ Liver cirrhosis| '''Liver cirrhosis''']]<ref name="pmid24076364">{{cite journal |vauthors=Ge PS, Runyon BA |title=The changing role of beta-blocker therapy in patients with cirrhosis |journal=J. Hepatol. |volume=60 |issue=3 |pages=643–53 |date=March 2014 |pmid=24076364 |doi=10.1016/j.jhep.2013.09.016 |url=}}</ref><ref name="pmid3533689">{{cite journal |vauthors=Becker CD, Scheidegger J, Marincek B |title=Hepatic vein occlusion: morphologic features on computed tomography and ultrasonography |journal=Gastrointest Radiol |volume=11 |issue=4 |pages=305–11 |date=1986 |pmid=3533689 |doi= |url=}}</ref><ref name="pmid3532188">{{cite journal |vauthors=Giorgio A, Amoroso P, Lettieri G, Fico P, de Stefano G, Finelli L, Scala V, Tarantino L, Pierri P, Pesce G |title=Cirrhosis: value of caudate to right lobe ratio in diagnosis with US |journal=Radiology |volume=161 |issue=2 |pages=443–5 |date=November 1986 |pmid=3532188 |doi=10.1148/radiology.161.2.3532188 |url=}}</ref>
|[[ Liver cirrhosis| '''Liver cirrhosis''']]<ref name="pmid24076364">{{cite journal |vauthors=Ge PS, Runyon BA |title=The changing role of beta-blocker therapy in patients with cirrhosis |journal=J. Hepatol. |volume=60 |issue=3 |pages=643–53 |date=March 2014 |pmid=24076364 |doi=10.1016/j.jhep.2013.09.016 |url=}}</ref><ref name="pmid3533689">{{cite journal |vauthors=Becker CD, Scheidegger J, Marincek B |title=Hepatic vein occlusion: morphologic features on computed tomography and ultrasonography |journal=Gastrointest Radiol |volume=11 |issue=4 |pages=305–11 |date=1986 |pmid=3533689 |doi= |url=}}</ref><ref name="pmid3532188">{{cite journal |vauthors=Giorgio A, Amoroso P, Lettieri G, Fico P, de Stefano G, Finelli L, Scala V, Tarantino L, Pierri P, Pesce G |title=Cirrhosis: value of caudate to right lobe ratio in diagnosis with US |journal=Radiology |volume=161 |issue=2 |pages=443–5 |date=November 1986 |pmid=3532188 |doi=10.1148/radiology.161.2.3532188 |url=}}</ref>
Line 663: Line 733:
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+/-</nowiki>
|<nowiki>+/-</nowiki>
|*N/A
|
|*N/A
*N/A
|*N/A
|
|*N/A
*N/A
|*N/A
|
*N/A
|
*N/A
|
*N/A
|
|
* Liver function testing is crucial for diagnosis
* Liver function testing is crucial for diagnosis
Line 760: Line 835:
** Mediastinal widening  
** Mediastinal widening  
** [[Aortic dissection]]
** [[Aortic dissection]]
|*N/A
|
|*N/A
*N/A
|
*N/A
|
|
* Electrocardiography may indicate the following:
* Electrocardiography may indicate the following:
Line 770: Line 847:
** Left atrial enlargement  
** Left atrial enlargement  
** Left ventricular [[hypertrophy]]
** Left ventricular [[hypertrophy]]
|*N/A
|
*N/A
|}
|}


==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 15:40, 2 May 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]

Differential Oliguria

Classification by etiology Etiology Clinical manifestations Paraclinical findings Comments
Symptoms and signs Lab findings Imaging
Fatigue/Lethargy Thirst Dizziness/Confusion Muscle weakness/cramp Somatic/visceral pain Vomiting Diarrhea Tachypnea Haematuria/Proteinuria Edema Blood tests KFT Electrolytes Urine analysis ABG Other Ultrasound X-ray CT MRI Other
Prerenal Alcohol poisoning[1][2][3][4] + - +/- - +/- + +/- - - - Prolonged PT Elevated creatinine with normal BUN may indicate isopropyl alcohol poisoning
  • N/A
  • N/A
  • N/A
  • N/A
  • N/A
  • N/A
Aspergillosis[5][6][7] +/- - - - - - - +/- - -
  • N/A
  • N/A
  • N/A
  • N/A
  • N/A
  • N/A
  • Pulmonary infiltrates
  • Mucoid plugging
  • Central bronchiectasis
  • Mass in the upper lobe surrounded by a crescent of air
  • Solitary or multiple cavities
  • Halo sign (ground-glass appearance with nodules)
  • Defines bronchiectasis
  • May show evidence of wedge-shaped pulmonary infarction
  • Granulomata, tissue necrosis, and blood vessel invasion may be noted
  • N/A
  • N/A
Cholera[8][9][9][10] +/- + - - - +/- + - - -
  • N/A
  • Stool is used in dark field examination or PCR to visualize vibrio cholerae
  • Stool culture is carried out using thiosulfate-citrate-bile-sucrose-agar
  • Serotyping may be performed using an anti-serum
  • Elevated serum protein is noted
  • Elevated serum-specific gravity is noted
  • Elevated blood glucose may be detected
  • N/A
  • N/A
  • N/A
  • N/A
  • N/A
  • N/A
Congestive heart failure (CHF)[11][12][13][14][15][16] + - - - - - + - - +
  • N/A
  • N/A
  • N/A
  • N/A
Dehydration[17][18][19][20]

- Burns

-Cutaneous loss e.g. sweating

- Inadequate water intake

- Salt-wasting nephropathy

+ + - +/- - +/- +/- - - -
  • N/A
  • Ketones and glucose] may be detected
  • Urine specific gravity is elevated
  • N/A
  • N/A
  • N/A
  • N/A
  • N/A
Diarrhea and/or vomiting[21][22][23][24] +/- +/- - - - + + - - -
  • N/A
  • Stool anion gap should be calculated
  • N/A
  • Abdominal ultrasound may be useful to detect cause
  • Upper gastrointestinal radiography with follow-through may be useful to detect cause
  • N/A
  • Brain MRI may be useful to detect cause
  • Esophagogastroduodenoscopy may be useful to detect cause
  • Treatment must include volume replacement
Drugs/toxins[25][26][27][28]

- ACE inhibitor

- Aminoglycosides

- Amphotericin B

- Contrast material

- Cyclosporin

- Diuretics

- Digitalis

- Heavy metals

- Indomethacin

- Tacrolimus

- NSAIDs

+/- +/- +/- +/- +/- +/- +/- +/- +/- +/-
  • N/A
  • Blood glucose should be measured
  • Toxicology screening is crucial in aiding diagnosis
  • Rapid immunoassay screens may also aid diagnosis
  • Useful in drug-induced nephropathies
  • Some radio-opaque substances may be visualized
  • Ingested drug packets may also be visualized
  • N/A
  • N/A
  • N/A
Esophageal varices bleeding[29][30] +/- - - - +/- - - - - -
  • N/A
  • N/A
  • N/A
  • N/A
  • Duplex doppler ultrasonography can determine:
    • Velocity and direction of portal flow
    • Determine portal vein patency
  • Endoscopic ultrasonography may also be useful
  • Abnormal opacities representing paraesophageal varices may be detected outside the esophageal wall
  • The short or long segment of the descending aorta may be obliterated
  • A posterior mediastinal or intraparenchymal mass may be noted
  • A dilated azygous vein may be noted and is described as a "downhill varix"
  • Dilated collaterals may lead to a widened superior mediastinum
  • Barium swallow demonstrates snake-like filling defects
  • Can visualize the entire portal venous system
  • N/A
Heart disease[31][32]

-Congenital

-Acquired

+/- - - - - - - +/- - +/-
  • N/A
  • N/A
  • N/A
  • Ultrasound visualizes anatomy of the heart and in particular, the chambers and chamber flow
  • N/A
  • N/A
  • History and physical examination (auscultation of the heart) are important for diagnosis
Hemorrhage[33][34][35][36] - - - - - - - - - -
  • N/A
  • N/A
-
  • Sensitive to bleeding within body cavities
  • Focused abdominal sonographic technique (FAST) can detect peritoneal cavity fluid
  • Chest x - ray may demonstrate bilateral opacities in the lung field and indicate hemothorax
  • Abdominal x - ray may demonstrate hemoperitoneum
  • Incomplete calcified margins of a dilated aorta may indicate a ruptured abdominal aortic aneurysm
  • Absence of the psoas shadow may suggest retroperitoneal blood
  • May visualize intrathoracic, intra-abdominal, and retroperitoneal bleeding
  • However, ultrasound is more often used
  • N/A
  • Esophagogastroduodenoscopy is often used to visualize the source of bleeding in the upper GI
  • Colonoscopy may be used in the lower GI
  • Angiography and nuclear medicine scanning are also useful in diagnosing the source of bleeding
  • N/A
Hemolysis[37][38][39][40] +/- - - - - - - - +/- -
  • N/A
  • N/A
  • N/A
  • N/A
  • N/A
  • N/A
  • N/A
  • N/A
  • N/A
Hepatorenal syndrome[41][42][43][44] +/- - - - +/- +/- - - +/- +/-
  • N/A
  • Abdominal ultrasound to exclude hydronephrosis and intrinsic renal disease
  • N/A
  • N/A
  • N/A
  • Echocardiography is used to evaluate right ventricular preload, ventricular filling pressures, and cardiac function
  • N/A
Ischemic cardiomyopathy[45][46][47][48] +/- - - - - - - +/- - +/-
  • N/A
  • N/A
  • N/A
  • May detect abnormal cardiac silhouette
  • MRI with gadolinium–diethylene-triamine pentaacetic acid (DTPA) can evaluate mid-wall fibrosis
  • N/A
Liver cirrhosis[49][50][51] +/- - +/- +/- +/- - - - - +/-
  • N/A
  • N/A
  • N/A
  • N/A
  • N/A
Malignant hypertension[52][53] +/- - + - - +/- - +/- - +/- -
  • N/A
  • N/A
  • Electrocardiography may indicate the following:
    • Ischemia
    • Infarct
    • Evidence of electrolyte abnormalities or drug overdose
  • Echocardiography may indicate the following:
  • N/A

References

  1. Pletcher MJ, Maselli J, Gonzales R (December 2004). "Uncomplicated alcohol intoxication in the emergency department: an analysis of the National Hospital Ambulatory Medical Care Survey". Am. J. Med. 117 (11): 863–7. doi:10.1016/j.amjmed.2004.07.042. PMID 15589492.
  2. Cherpitel CJ (March 1989). "Breath analysis and self-reports as measures of alcohol-related emergency room admissions". J. Stud. Alcohol. 50 (2): 155–61. PMID 2927129.
  3. Yost DA (December 2002). "Acute care for alcohol intoxication. Be prepared to consider clinical dilemmas". Postgrad Med. 112 (6): 14–6, 21–2, 25–6. PMID 12510444.
  4. Boba A (July 1999). "Management of acute alcoholic intoxication". Am J Emerg Med. 17 (4): 431. PMID 10452451.
  5. Marr KA, Carter RA, Crippa F, Wald A, Corey L (April 2002). "Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients". Clin. Infect. Dis. 34 (7): 909–17. doi:10.1086/339202. PMID 11880955.
  6. Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic C, Chevrier S, Meunier C, Lebert C, Aupée M, Caulet-Maugendre S, Faucheux M, Lelong B, Leray E, Guiguen C, Gangneux JP (September 2006). "Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey". Clin. Infect. Dis. 43 (5): 577–84. doi:10.1086/505870. PMID 16886149.
  7. Horger M, Hebart H, Einsele H, Lengerke C, Claussen CD, Vonthein R, Pfannenberg C (September 2005). "Initial CT manifestations of invasive pulmonary aspergillosis in 45 non-HIV immunocompromised patients: association with patient outcome?". Eur J Radiol. 55 (3): 437–44. doi:10.1016/j.ejrad.2005.01.001. PMID 16129254.
  8. Weil AA, Khan AI, Chowdhury F, Larocque RC, Faruque AS, Ryan ET, Calderwood SB, Qadri F, Harris JB (November 2009). "Clinical outcomes in household contacts of patients with cholera in Bangladesh". Clin. Infect. Dis. 49 (10): 1473–9. doi:10.1086/644779. PMC 2783773. PMID 19842974.
  9. 9.0 9.1 Cash RA, Music SI, Libonati JP, Snyder MJ, Wenzel RP, Hornick RB (January 1974). "Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum". J. Infect. Dis. 129 (1): 45–52. PMID 4809112.
  10. Harris JB, Ivers LC, Ferraro MJ (June 2011). "Case records of the Massachusetts General Hospital. Case 19-2011. A 4-year-old Haitian boy with vomiting and diarrhea". N. Engl. J. Med. 364 (25): 2452–61. doi:10.1056/NEJMcpc1100927. PMID 21696312.
  11. Solomon SD, Dobson J, Pocock S, Skali H, McMurray JJ, Granger CB, Yusuf S, Swedberg K, Young JB, Michelson EL, Pfeffer MA (September 2007). "Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure". Circulation. 116 (13): 1482–7. doi:10.1161/CIRCULATIONAHA.107.696906. PMID 17724259.
  12. Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ (February 2005). "Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis". JAMA. 293 (5): 572–80. doi:10.1001/jama.293.5.572. PMID 15687312.
  13. Kittleson M, Hurwitz S, Shah MR, Nohria A, Lewis E, Givertz M, Fang J, Jarcho J, Mudge G, Stevenson LW (June 2003). "Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality". J. Am. Coll. Cardiol. 41 (11): 2029–35. PMID 12798577.
  14. Filippatos G, Rossi J, Lloyd-Jones DM, Stough WG, Ouyang J, Shin DD, O'connor C, Adams KF, Orlandi C, Gheorghiade M (June 2007). "Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study". J. Card. Fail. 13 (5): 360–4. doi:10.1016/j.cardfail.2007.02.005. PMID 17602982.
  15. Zamora E, Lupón J, Vila J, Urrutia A, de Antonio M, Sanz H, Grau M, Ara J, Bayés-Genís A (May 2012). "Estimated glomerular filtration rate and prognosis in heart failure: value of the Modification of Diet in Renal Disease Study-4, chronic kidney disease epidemiology collaboration, and cockroft-gault formulas". J. Am. Coll. Cardiol. 59 (19): 1709–15. doi:10.1016/j.jacc.2011.11.066. PMID 22554602.
  16. McAlister FA, Ezekowitz J, Tarantini L, Squire I, Komajda M, Bayes-Genis A, Gotsman I, Whalley G, Earle N, Poppe KK, Doughty RN (May 2012). "Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula". Circ Heart Fail. 5 (3): 309–14. doi:10.1161/CIRCHEARTFAILURE.111.966242. PMID 22441773.
  17. Steiner MJ, DeWalt DA, Byerley JS (June 2004). "Is this child dehydrated?". JAMA. 291 (22): 2746–54. doi:10.1001/jama.291.22.2746. PMID 15187057.
  18. Vega RM, Avner JR (June 1997). "A prospective study of the usefulness of clinical and laboratory parameters for predicting percentage of dehydration in children". Pediatr Emerg Care. 13 (3): 179–82. PMID 9220501.
  19. Dossetor JB (December 1966). "Creatininemia versus uremia. The relative significance of blood urea nitrogen and serum creatinine concentrations in azotemia". Ann. Intern. Med. 65 (6): 1287–99. PMID 5928490.
  20. Baskett PJ (June 1990). "ABC of major trauma. Management of hypovolaemic shock". BMJ. 300 (6737): 1453–7. PMC 1663124. PMID 2198971.
  21. Carpenter DO (February 1990). "Neural mechanisms of emesis". Can. J. Physiol. Pharmacol. 68 (2): 230–6. PMID 2178747.
  22. Bresee JS, Marcus R, Venezia RA, Keene WE, Morse D, Thanassi M, Brunett P, Bulens S, Beard RS, Dauphin LA, Slutsker L, Bopp C, Eberhard M, Hall A, Vinje J, Monroe SS, Glass RI (May 2012). "The etiology of severe acute gastroenteritis among adults visiting emergency departments in the United States". J. Infect. Dis. 205 (9): 1374–81. doi:10.1093/infdis/jis206. PMID 22454468.
  23. Hall AJ, Rosenthal M, Gregoricus N, Greene SA, Ferguson J, Henao OL, Vinjé J, Lopman BA, Parashar UD, Widdowson MA (August 2011). "Incidence of acute gastroenteritis and role of norovirus, Georgia, USA, 2004-2005". Emerging Infect. Dis. 17 (8): 1381–8. doi:10.3201/eid1708.101533. PMC 3381564. PMID 21801613.
  24. Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, Langley JM, Wanke C, Warren CA, Cheng AC, Cantey J, Pickering LK (November 2017). "2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea". Clin. Infect. Dis. 65 (12): e45–e80. doi:10.1093/cid/cix669. PMID 29053792.
  25. Toto RD, Mitchell HC, Lee HC, Milam C, Pettinger WA (October 1991). "Reversible renal insufficiency due to angiotensin converting enzyme inhibitors in hypertensive nephrosclerosis". Ann. Intern. Med. 115 (7): 513–9. PMID 1883120.
  26. Bismuth C, Gaultier M, Conso F, Efthymiou ML (1973). "Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications". Clin. Toxicol. 6 (2): 153–62. doi:10.3109/15563657308990513. PMID 4715199.
  27. Sawaya BP, Briggs JP, Schnermann J (August 1995). "Amphotericin B nephrotoxicity: the adverse consequences of altered membrane properties". J. Am. Soc. Nephrol. 6 (2): 154–64. PMID 7579079.
  28. Whelton A (May 1999). "Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications". Am. J. Med. 106 (5B): 13S–24S. PMID 10390124.
  29. Graham DY, Smith JL (April 1981). "The course of patients after variceal hemorrhage". Gastroenterology. 80 (4): 800–9. PMID 6970703.
  30. de Franchis R (October 2010). "Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension". J. Hepatol. 53 (4): 762–8. doi:10.1016/j.jhep.2010.06.004. PMID 20638742.
  31. LaCroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, Curb JD, Evans D, Hennekens CH (June 1991). "Smoking and mortality among older men and women in three communities". N. Engl. J. Med. 324 (23): 1619–25. doi:10.1056/NEJM199106063242303. PMID 2030718.
  32. Mahle WT, Newburger JW, Matherne GP, Smith FC, Hoke TR, Koppel R, Gidding SS, Beekman RH, Grosse SD (August 2009). "Role of pulse oximetry in examining newborns for congenital heart disease: a scientific statement from the AHA and AAP". Pediatrics. 124 (2): 823–36. doi:10.1542/peds.2009-1397. PMID 19581259.
  33. Achneck HE, Sileshi B, Parikh A, Milano CA, Welsby IJ, Lawson JH (November 2010). "Pathophysiology of bleeding and clotting in the cardiac surgery patient: from vascular endothelium to circulatory assist device surface". Circulation. 122 (20): 2068–77. doi:10.1161/CIRCULATIONAHA.110.936773. PMID 21098468.
  34. Gralnick HR, Rick ME, McKeown LP, Williams SB, Parker RI, Maisonneuve P, Jenneau C, Sultan Y (July 1986). "Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's disease". Blood. 68 (1): 58–61. PMID 3487361.
  35. Suchman AL, Griner PF (June 1986). "Diagnostic uses of the activated partial thromboplastin time and prothrombin time". Ann. Intern. Med. 104 (6): 810–6. PMID 3706933.
  36. Greenberg CS, Devine DV, McCrae KM (January 1987). "Measurement of plasma fibrin D-dimer levels with the use of a monoclonal antibody coupled to latex beads". Am. J. Clin. Pathol. 87 (1): 94–100. PMID 3541576.
  37. Liesveld JL, Rowe JM, Lichtman MA (March 1987). "Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases". Blood. 69 (3): 820–6. PMID 3814817.
  38. Marchand A, Galen RS, Van Lente F (May 1980). "The predictive value of serum haptoglobin in hemolytic disease". JAMA. 243 (19): 1909–11. PMID 7365971.
  39. Stahl WM (June 1987). "Acute phase protein response to tissue injury". Crit. Care Med. 15 (6): 545–50. PMID 2436855.
  40. Conley CL, Lippman SM, Ness P (October 1980). "Autoimmune hemolytic anemia with reticulocytopenia. A medical emergency". JAMA. 244 (15): 1688–90. PMID 7411826.
  41. Ginès P, Schrier RW (September 2009). "Renal failure in cirrhosis". N. Engl. J. Med. 361 (13): 1279–90. doi:10.1056/NEJMra0809139. PMID 19776409.
  42. Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Schölmerich J (January 1996). "Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club". Hepatology. 23 (1): 164–76. doi:10.1002/hep.510230122. PMID 8550036.
  43. Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V (September 2007). "Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis". Gut. 56 (9): 1310–8. doi:10.1136/gut.2006.107789. PMC 1954971. PMID 17389705.
  44. Angeli P, Ginès P, Wong F, Bernardi M, Boyer TD, Gerbes A, Moreau R, Jalan R, Sarin SK, Piano S, Moore K, Lee SS, Durand F, Salerno F, Caraceni P, Kim WR, Arroyo V, Garcia-Tsao G (April 2015). "Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites". J. Hepatol. 62 (4): 968–74. doi:10.1016/j.jhep.2014.12.029. PMID 25638527.
  45. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB (April 2006). "Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention". Circulation. 113 (14): 1807–16. doi:10.1161/CIRCULATIONAHA.106.174287. PMID 16567565.
  46. Corrado D, Pelliccia A, Bjørnstad HH, Vanhees L, Biffi A, Borjesson M, Panhuyzen-Goedkoop N, Deligiannis A, Solberg E, Dugmore D, Mellwig KP, Assanelli D, Delise P, van-Buuren F, Anastasakis A, Heidbuchel H, Hoffmann E, Fagard R, Priori SG, Basso C, Arbustini E, Blomstrom-Lundqvist C, McKenna WJ, Thiene G (March 2005). "Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology". Eur. Heart J. 26 (5): 516–24. doi:10.1093/eurheartj/ehi108. PMID 15689345.
  47. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A (January 2008). "Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases". Eur. Heart J. 29 (2): 270–6. doi:10.1093/eurheartj/ehm342. PMID 17916581.
  48. Thompson PD, Franklin BA, Balady GJ, Blair SN, Corrado D, Estes NA, Fulton JE, Gordon NF, Haskell WL, Link MS, Maron BJ, Mittleman MA, Pelliccia A, Wenger NK, Willich SN, Costa F (May 2007). "Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism and the Council on Clinical Cardiology". Circulation. 115 (17): 2358–68. doi:10.1161/CIRCULATIONAHA.107.181485. PMID 17468391.
  49. Ge PS, Runyon BA (March 2014). "The changing role of beta-blocker therapy in patients with cirrhosis". J. Hepatol. 60 (3): 643–53. doi:10.1016/j.jhep.2013.09.016. PMID 24076364.
  50. Becker CD, Scheidegger J, Marincek B (1986). "Hepatic vein occlusion: morphologic features on computed tomography and ultrasonography". Gastrointest Radiol. 11 (4): 305–11. PMID 3533689.
  51. Giorgio A, Amoroso P, Lettieri G, Fico P, de Stefano G, Finelli L, Scala V, Tarantino L, Pierri P, Pesce G (November 1986). "Cirrhosis: value of caudate to right lobe ratio in diagnosis with US". Radiology. 161 (2): 443–5. doi:10.1148/radiology.161.2.3532188. PMID 3532188.
  52. Johnson W, Nguyen ML, Patel R (November 2012). "Hypertension crisis in the emergency department". Cardiol Clin. 30 (4): 533–43. doi:10.1016/j.ccl.2012.07.011. PMID 23102030.
  53. Elliott WJ (2006). "Clinical features in the management of selected hypertensive emergencies". Prog Cardiovasc Dis. 48 (5): 316–25. doi:10.1016/j.pcad.2006.02.004. PMID 16627047.